召开业绩说明会，上市公司应强化责任意识，切实履行信息披露义务，真正以投资者利益为出发点，全 面、客观地回应投资者关切。会前，应充分准备，制定合理的答复策略；会中，应秉持坦诚态度，积极 面对投资者的质疑，不回避、不敷衍。投资者自身也应提高专业素养和辨别能力，针对性提问、持续追 问，积极维护自身合法权益。 资本市场的健康稳定发展离不开高质量的信息披露，业绩说明会作为重要环节之一，不容被"选择性"对 待。上市公司、监管部门和投资者需共同努力，让业绩说明会回归本质，发挥其应有的作用，为资本市 场营造公平、透明、有序的环境。 （文章来源：证券时报） "选择性说明"危害不容小视。首先，投资者依据公司披露的信息进行价值判断和投资决策。"选择性说 明"让投资者难以准确获取公司信息，投资决策易被误导。其次，"选择性说明"让业绩说明会流于形 式，损害了投资者对公司的信任，破坏了资本市场的诚信环境。再次，信息披露是资本市场的基石，这 种不良示范极易引发效仿，让资本市场整体的信息披露质量打了折扣。 但我们也看到，越来越多的上市公司开始主动行动，在会前广泛搜集问题，在会上积极回应关切。一场 说明会下来，几十个问答，堪比新闻发布会。管理 ...

Group 1 - The company will hold an investor briefing on May 26, 2025, from 11:00 to 12:00 to discuss the 2024 annual and 2025 Q1 performance [1][2] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online interactive text format [2][3] - Key personnel attending the meeting include the Chairwoman Chen Lina, General Manager Cai Linlin, Independent Director Yan Yajun, Board Secretary Huang Xuan, and CFO Wu Shufei [2] Group 2 - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [3] - Questions can be submitted by investors from May 19 to May 23, 2025, through the Roadshow Center website or via the company's email [3] - After the briefing, investors can access the main content and details of the meeting on the Roadshow Center website [3]

Group 1 - The company held its 2024 annual performance briefing on May 14, 2025, via the "Panorama Roadshow" website, allowing for interactive communication with investors regarding its operational results and financial indicators [1][2][3] - Key executives, including the president and financial director, participated in the briefing to address investor inquiries [2] - The company expressed gratitude for the long-term support and attention from investors [3] Group 2 - The company’s board of directors convened a temporary meeting on May 12, 2025, to discuss and approve various proposals, including providing guarantees for its subsidiary [5][6] - The board approved a guarantee for its subsidiary, Guancheng Ruimin, amounting to 168 million yuan, with collateral provided by the company’s shares in Fudian Bank [6][12] - The board also agreed to hold the first temporary shareholders' meeting of 2025 on May 30, 2025, to review the guarantee proposal [8][19] Group 3 - The company has provided a total of 154.11 million yuan in guarantees, which represents 26.35% of its latest audited net assets [18] - If all proposed guarantees are executed, the total would exceed 311.19 million yuan, accounting for 53.21% of the company's latest audited net assets [18] - The company’s subsidiary, Guancheng Ruimin, has a debt-to-asset ratio exceeding 70%, necessitating careful monitoring of financial risks associated with the guarantees [12][16]

Group 1: Company Performance and Strategy - The company has adjusted its strategic planning to focus on self-produced products, maintaining the performance growth of its core product, Miglitol tablets, which has seen an increasing proportion of total revenue [2][5]. - The revenue from third-party cooperative products has gradually declined, leading to the termination of such collaborations [2]. - The company aims to explore the clinical value of existing products and plans to launch some dormant products, enhancing its product system through various means [2][5]. Group 2: Financial Management and Investor Relations - The company reported a profit increase for 2024, primarily due to the absence of a goodwill impairment charge of CNY 19.8 million that was recorded in 2023 [5]. - The board of directors has proposed a profit distribution plan for 2024, which will be submitted for approval at the annual shareholders' meeting [3]. - The company emphasizes the importance of rational investment and risk awareness due to the influence of macroeconomic factors on stock prices [3][6]. Group 3: Shareholder Concerns and Corporate Governance - The reduction of shares by a board member is attributed to personal financial needs, with no intention of exiting the board [1][2]. - The company has no current plans for a private placement, despite having idle funds for financial management [3]. - The management reassures investors of their confidence in the company's future development and industry prospects [3][5]. Group 4: Product Development and Market Position - The company is focused on developing core products for chronic diseases and women's health, with an emphasis on maintaining stable operations [4][5]. - The core product, Miglitol tablets, is highlighted as a key focus area for the company [7]. - The company is exploring new product introductions and partnerships to enhance its market position [5][6].

证券代码：688008 证券简称：澜起科技 公告编号：2025-018 澜起科技股份有限公司 关于召开 2024 年度暨 2025 年第一季度 业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 会议召开时间：2025 年 5 月 21 日（星期三）下午 15:00-16:00 （http://roadshow.sseinfo.com） ? 会议召开地点：上海证券交易所"上证路演中心" ? 会议召开方式：视频结合网络文字互动 ? 投资者可于 2025 年 5 月 14 日（星期三）至 5 月 20 日（星期二）16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@montagetech.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 澜起科技股份有限公司（以下简称"公司"）分别于 2025 年 4 月 11 日、2025 年 4 月 24 日在上海证券交易所网站（www.sse.com.cn）披露公司《2024 年年度 报告》及其摘要、《 ...

Group 1: Financial Performance and Taxation - The company will continue to recognize stock incentive expenses in 2025, specifically for 21,100 restricted shares allocated to 5 incentive recipients from the 2021 plan [1] - The income tax expense for Q4 2024 reached CNY 15 million, primarily due to the reduction in deductible amounts related to stock payment expenses after the lifting of restrictions on restricted shares [1] - The increase in sales expenses by CNY 10 million in Q1 is attributed to online promotion costs, which are considered non-recurring [2] Group 2: Business Development and Strategy - The 2025 business development plan includes increased investment in R&D and production resources for baked goods and frozen prepared dishes, aiming to meet customer demands for rapid innovation [2] - The company plans to explore C-end business opportunities, leveraging its R&D advantages to develop differentiated products and diversify sales channels, including e-commerce and traditional retail [2] - Efforts will be made to enhance operational efficiency across all business segments, focusing on cost control in procurement, production, and logistics [2] - Brand building and customer service quality will be prioritized to ensure sustainable and high-quality growth [2] Group 3: Production and Capacity Management - The company operates through self-production, commissioned processing, and outsourcing, with most core products being self-produced [3] - In 2024, 20,000 tons of products were processed through commissioned processing, primarily for items like sesame balls and spring rolls, which are produced using standard equipment and processes [3] - Future decisions on converting commissioned processing to self-production will depend on market conditions and operational assessments [3] Group 4: Financing Plans - The company plans to raise CNY 300 million through a simplified procedure for issuing shares to specific investors, pending approval from the 2024 annual shareholders' meeting [4] - The specific use of the funds for acquisitions or expansion of production has not yet been determined, and further disclosures will be made as developments occur [4]

Group 1 - The company, Xi'an Aike Saibo Electric Co., Ltd., has approved a share repurchase plan to buy back 2 million to 4 million shares at a maximum price of RMB 41.67 per share, with a total estimated expenditure of RMB 83.34 million to 166.68 million [2] - The repurchase will be funded through the company's own funds and a special loan from CITIC Bank, and the shares will be used for employee stock ownership plans or equity incentives [2][3] - As of April 30, 2025, the company has repurchased a total of 3,523,378 shares, accounting for 3.0536% of the total share capital, with a total expenditure of RMB 102,493,674.80 [3][4] Group 2 - The company will hold an annual performance briefing on May 16, 2025, to discuss its 2024 annual report and the first quarter of 2025, allowing investors to submit questions in advance [8][9] - The briefing will be conducted online, and key personnel including the chairman and financial director will participate [10][11] - Investors can access the briefing through a designated website and will be able to view the main content afterward [12]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688638 证券简称：誉辰智能 公告编号：2025-025 深圳市誉辰智能装备股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 一、回购股份的基本情况 公司于2024年4月26日召开第一届董事会第十七次会议，审议通过了《关于以集中竞价交易方式回购公 司股份方案的议案》，并于2024年5月24日召开2023年年度股东大会审议通过前述议案，同意公司使用 首次公开发行人民币普通股取得的部分超募资金，通过上海证券交易所交易系统以集中竞价交易方式回 购公司部分股份，回购股份将用于员工持股计划或者股权激励，回购资金总额不低于人民币3,000万元 （含），不超过人民币5,000万元（含），具体回购股份数量及公司股权结构实际变动情况以后续实施 情况为准。回购期限自公司股东大会审议通过本次回购方案之日起12个月内。具体内容详见公司于2024 年4月27日披露于上海证券交易所网站（www.sse.com.cn）的《深圳市誉辰智能装备 ...

Group 1 - The investor presentation was held in an interactive online format, allowing company management to communicate with investors regarding the basic situation and operational results for the year 2024 and the first quarter of 2025 [2][3]. - The meeting took place on April 30, 2025, from 9:00 to 10:00 AM [3]. - Key participants included the Chairman, Secretary of the Board and CFO, and an Independent Director [4]. Group 2 - The company reported that the polypropylene processing trade volume is approximately 50,000 tons, with profit margins comparable to domestic levels [7]. - The increase in gross profit margin for Q1 was attributed to several factors, including depreciation adjustments, reduced comprehensive costs from the second phase of the olefin project, and high operating rates for major products [7][8]. - The company indicated that the decline in coking coal prices is beneficial for coking profit margins [7]. - The gross profit margin for Q1 significantly increased to 5%, with expectations for an overall annual increase in gross profit margin [8]. - The operating rates for the company's main products are reported as 109% for carbon black, 91% for olefins, and 84% for coking, all exceeding industry averages [8]. - The production volume of coking products for 2024 is projected at 2.1014 million tons, with a design capacity of 1.7 million tons, resulting in a capacity utilization rate of 82.33% [8]. - A significant decrease of 56.26% in cash flow from operating activities was noted, primarily due to adjustments related to bank acceptance bills among subsidiaries [8]. - The company forecasts sales revenue of 18.7 billion and net profit of 328 million for 2025, based on market assessments and production conditions [8].

Group 1: Sales and Financial Performance - In 2024, the company achieved operating revenue of 654 million RMB, an increase of 9.67% compared to 2023 [4] - The net profit attributable to shareholders reached 27.12 million RMB, up 206.84% from 2023 [4] - The cash flow from operating activities was -16.04 million RMB in 2024, primarily due to increased procurement payments and strategic inventory buildup [3] Group 2: Product and Market Insights - The company's overseas sales amounted to 80.35 million RMB, accounting for 12.38% of total sales, with key markets including Indonesia, Poland, Taiwan, and Mexico [3] - The high-margin product, prism-type dot technology, has a gross margin of approximately 40%, contributing significantly to profitability [4] - The company plans to expand its product applications into high-value sectors such as automotive and industrial control [5] Group 3: Research and Development - In 2024, R&D expenses were 3.51 million RMB, representing a 20% increase from 2023, with R&D spending as a percentage of revenue continuing to rise [3] - The R&D team consists of 92 professionals with expertise in optics, materials science, mathematics, and automation [3] Group 4: Strategic Initiatives and Future Outlook - The company is focused on enhancing its competitive edge through continuous product innovation and maintaining strong communication with investors [4] - The TAC film project is progressing well, with equipment procurement and investor engagement underway [4] - The company has established a comprehensive quality control system and aims to maintain its reputation in the industry [4]